Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Tutt, Andrew, Dr, Robson, Mark, MD, Garber, Judy E, MD, Domchek, Susan M, MD, Audeh, M William, MD, Weitzel, Jeffrey N, Prof, Friedlander, Michael, Prof, Arun, Banu, Prof, Loman, Niklas, MD, Schmutzler, Rita K, Prof, Wardley, Andrew, MD, Mitchell, Gillian, MD, Earl, Helena, PhD, Wickens, Mark, BSc, Carmichael, James, Prof
Published in The Lancet (British edition) (24.07.2010)
Published in The Lancet (British edition) (24.07.2010)
Get full text
Journal Article